Drug Trial Radar · NCT07091630
A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
Last checked: Nov 19, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
160
Planned (sponsor's estimate)
Start
Sep 16, 2025
Primary completion
Oct 7, 2027
Study completion Jan 23, 2031
Sponsor
- Lead sponsor
- argenxargenx (ARGX)
- Sponsor type
- Industry
- First posted
- Jul 29, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main purpose of this study is to demonstrate the efficacy and safety of empasiprubart in adults with CIDP. The study consists of a part A where participants will either receive empasiprubart or placebo for 24 weeks (6 months). Following part A, participants will enter part B in which all participants will receive empasiprubart for 96 weeks (24 months). More information can be found here: https://clinicaltrials.argenx.com/emnergize
Conditions
- Chronic Inflammatory Demyelinating Polyneuropathy
- CIDP
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Interventions
Empasiprubart IVBiological
Intravenous infusion of empasiprubart
Placebo IVOther
Intravenous infusion of placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Reduction of ≥1 point compared with baseline in aINCAT score at week 24Time frame: Up to 24 weeks
Locations
95 sites in 25 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham - 1720 University Blvd
Birmingham, Alabama · Recruiting
Banner University of Arizona Medical Center
Tucson, Arizona · Recruiting
Samir Macwan, M.D., Inc. (S corporation)
Rancho Mirage, California · Recruiting
Colorado Springs Neurological Associates
Colorado Springs, Colorado · Recruiting
Medstar Health Research Institute
Washington D.C., District of Columbia · Recruiting
Gables Neurology
Miami, Florida · Recruiting
Aqualane Clinical Research
Naples, Florida · Recruiting
Vero Beach Neurology and Research Institute
Vero Beach, Florida · Recruiting
Paradigm Health System
Slidell, Louisiana · Recruiting
Penn Medicine University City
Philadelphia, Pennsylvania · Recruiting
Jefferson Health Honickman Center
Philadelphia, Pennsylvania · Recruiting
University Neurology
Knoxville, Tennessee · Recruiting
National Neuromuscular Research Institute
Austin, Texas · Recruiting
NeuroCarePlus
Houston, Texas · Recruiting
Instituto Privado Kremer
Córdoba, Argentina · Recruiting
Instituto Médico de la Fundación Estudios Clínicos
Rosario, Argentina · Recruiting
INECO Neurociencias Oroño
Rosario, Argentina · Recruiting
Universitätsklinikum AKH Wien
Vienna, Austria · Recruiting
Kepler Universitätsklinikum Linz - Med Campus III
Linz, Upper Austria, Austria · Recruiting
L2 Ip - Instituto de Pesquisas Clinicas Ltda - ME
Brasília, Brazil · Recruiting
Hospital Moinhos de Vento
Porto Alegre, Brazil · Recruiting
PSEG Centro de Pesquisa Clinica
São Paulo, Brazil · Recruiting
Escola Bahiana de Medicina e Saude Publica
Salvador, Estado de Bahia, Brazil · Recruiting
Unidade de Pesquisa Clinica e Inovacao da Estacio
Rio de Janeiro, Rio de Janeiro, Brazil · Recruiting
Hospital de Clinicas de Porto Alegre (HCPA) - PPDS
Pôrto Alegre, Rio Grande do Sul, Brazil · Recruiting
Hospital Das Clinicas da Faculdade de Medicina de Ribeirao Preto - UPS - PPDS
Ribeirão Preto, São Paulo, Brazil · Recruiting
University Multiprofile Hospital for Active Treatment
Pleven, Bulgaria · Recruiting
Medical Center Medika 2005 - Branch Sofia
Sofia, Bulgaria · Recruiting
University Multiprofile Hospital for Active Treatment Aleksandrovska EAD
Sofia, Bulgaria · Recruiting
University Multiprofile Hospital for Active Treatment and Emergency Medicine N. I. Pirogov EAD
Sofia, Bulgaria · Recruiting
Multiprofile Hospital for Active Treatment of Neurology and Psychiatry Sv. Naum EAD
Sofia, Sofia, Bulgaria · Recruiting
Peking University First Hospital - Changqiao Campus
Beijing, China · Recruiting
Guangdong Provincial Hospital of Chinese Medicine
Guangzhou, China · Recruiting
Nanfang Hospital Southern Medical University
Guangzhou, China · Recruiting
Guangzhou First People's Hospital
Guanzhou, China · Recruiting
The Second Affiliated Hospital of Nanchang University (Donghu Campus)
Nanchang, China · Recruiting
The First Affiliated Hospital of Soochow University
Suzhou, China · Recruiting
Xi'an Gaoxin Hospital
Xi'an, China · Recruiting
Fujian Medical University Union Hospital - Yushan Campus
Fuzhou, Fujian, China · Recruiting
The People's Hospital of Baiyun District Guangzhou
Guangzhou, Guangdong, China · Recruiting
Showing 40 of 95 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.